Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients

BACKGROUND: The ROS1 gene is a member of the “sevenless” subfamily of tyrosine-kinase insulin-receptor genes. ROS1-fusion rearrangement causes constitutive downstream signal transduction, with an oncogenic role in non-small-cell lung carcinoma (NSCLC). Fortunately, crizotinib, an ALK1 tyrosine-kinas...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Anurag, Saifi, Mumtaz, Batra, Ullas, Suryavanshi, M, Gupta, Kush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047993/
https://www.ncbi.nlm.nih.gov/pubmed/32158297
http://dx.doi.org/10.2147/LCTT.S244366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047993/
https://www.ncbi.nlm.nih.gov/pubmed/32158297
http://dx.doi.org/10.2147/LCTT.S244366

Ejemplares similares